Grant Funding Awarded to Advance Cancer Therapeutics Discovery
The CRUK (Cancer Research UK) Scotland Institute and Oxford Drug Design, a biotechnology company with core expertise in AI drug discovery, have announced that their joint application for the MRC (UK Medical Research Council) National Mouse Genetics Network (NMGN) Business Engagement Fund has been awarded.